Work

First-in-human study of AMG 386, a selective angiopoietin1/2-neutralizing peptibody, in adult patients with advanced solid tumors

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3522

Authors: L. S. Rosen, D. Hong, L. Chap, R. Kurzrock, A. Garcia, E. Rasmussen, L. Nguyen, Y. Hwang, C. Storgard, R. S. Herbst

Institutions: Amgen (United States), The University of Texas MD Anderson Cancer Center

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2533492923

Cites:

Cited by: 9

Related to: 10